Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-09-04

FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic topical product combining nystatin and triamcinolone acetonide (Sun Pharmaceutical Industries, Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin and Triamcinolone Acetonide (Nystatin and Triamcinolone Acetonide)

Snippet

SUPPL AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)